EGFR-NSCLC Market Size & Share Forecast, 2030 | UnivDatos
According to a new report published by UnivDatos, the EGFR-NSCLC Market was valued at USD 6,762.75 million in 2022 & is expected to grow at a CAGR of 6.7% from 2022-2030. The analysis has been segmented into Drug Type (Erlotinib, Afatinib, Gefitinib, Osimertinib, and Dacomitinib); Distribution Channel  (Offline and Online); Region/Country. The EGFR-NSCLC Market report has been...
0 Комментарии 0 Поделились 748 Просмотры 0 предпросмотр
Спонсоры
MyLiveRoom https://myliveroom.com